胸段桨叶电极脊髓刺激器植入在独立门诊手术中心是否安全
本研究回顾2015年1月至2020年12月在单一独立门诊手术中心连续接受胸段桨叶电极植入的46例患者,2例(4.3%)发生需返回手术室的术后即刻并发症,97.8%患者手术当日回家,30天和90天再入院率分别为4.3%和6.5%,作者认为其并发症率与医院环境相当,但需未来比较研究评估成本效益。
要点
- 46例胸段桨叶电极植入中2例(4.3%)发生术后即刻并发症需返回手术室。
- 97.8%患者手术当日出院回家,30天再入院率4.3%、90天6.5%。
- 作者认为独立门诊手术中心并发症率与医院环境相当,需未来比较研究评估成本效益。
核心结论
- 胸段椎板切开桨叶电极脊髓刺激器植入可在独立门诊手术中心进行,并发症率与医院环境相当;未来需比较研究评估临床结局与成本以确定门诊环境的成本效益。
研究设计与样本
- 回顾性查询2015年1月至2020年12月在单一独立门诊手术中心连续接受胸段桨叶电极植入的患者,收集人口学、围手术期和结局数据。
主要发现
- 共46例患者接受门诊胸段桨叶电极植入。
- 2例(4.3%)发生术后即刻并发症需返回门诊手术中心手术,其中1例为硬膜外血肿、1例为侧腹血肿。
- 除1例外(97.8%)患者手术当日出院回家。
- 30天和90天总再入院率分别为4.3%和6.5%。
- 1例(2.2%)因机械性并发症需再手术,随访期间未见器械相关感染。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal cord stimulation is an effective treatment modality for chronic pain. Although percutaneous leads are commonly placed in the outpatient setting, paddle leads are typically implanted in the inpatient setting. Given the substantial cost savings associated with the ambulatory setting, we aimed to demonstrate the feasibility and safety of thoracic paddle lead implantation in a freestanding ambulatory surgery center (ASC). METHODS: Consecutive patients undergoing thoracic paddle lead implantation at a single freestanding ASC from January 2015 to December 2020 were queried. Demographic, perioperative, and outcome data were collected. Primary outcomes were incidence of intraoperative or immediate postoperative complications and need for inpatient transfer. Secondary outcomes included readmission at 30 and 90 days and reoperation at 30 days, 90 days, and 1 year. RESULTS: A total of 46 patients underwent ambulatory thoracic paddle lead implantation over the study period. Two patients (4.3%) suffered an immediate postoperative complication requiring return to surgery at the ASC-one for an epidural hematoma, and one for a flank hematoma. All but one patient (97.8%) were discharged home on the day of surgery. The overall 30- and 90-day readmission rates were 4.3% and 6.5%, respectively. One patient (2.2%) required reoperation for a mechanical complication. No device-related infections were noted during the follow-up period. CONCLUSIONS: Thoracic laminotomy for paddle lead spinal cord stimulator implantation can be performed in a freestanding ASC with complication rates comparable to the hospital setting. Future comparative studies that assess clinical outcomes and cost are necessary to determine the cost-effectiveness of the ambulatory setting.
引用
- Monk SH, O'Brien M, Bernard JD, et al. Is Thoracic Paddle Lead Spinal Cord Stimulator Implantation Safe in an Ambulatory Surgery Center? World Neurosurg. 2022. PMID: 36379362. doi:10.1016/j.wneu.2022.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。